Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dogs sought for autoimmune disease study
‘Petechiae’ - a dog with immune mediated thrombocytopenia showing oral petechiae (oral small, pintpoint bleeding).

The RVC-led project aims to improve canine wellbeing. 

Pet owners of dogs with autoimmune diseases are being invited to take part in a study to improve the wellbeing of those diagnosed in the future.

The study is being led by Drs Barbara Glanemann and James Swann at the RVC, who have created an observational registry to gather information about dogs recently diagnosed with autoimmune disease.

The ‘ImmunoRegistry’ data will be collected in real-time over a year after diagnosis to find out how the dogs respond to treatment.

Dr Glanemann explained: “We are looking to observe as many dogs as possible so that we can examine the data and ultimately share more informed advice and guidance with vets, and in turn, owners.

“This ambitious project relies on the enthusiasm and support of dog owners, and we look forward to using our results to improve the wellbeing of any dog diagnosed with immune-mediated disease in the future.”

The observational registry will collect data on dogs diagnosed in local practices and specialist hospitals. Researchers will then use the information to examine the prognosis associated with the diseases, if there are risks or relapse and whether medication works better in certain dog breeds. 

In particular, the team is seeking dogs diagnosed with IMHA, ITP, IMPA or SRMA. To meet the criteria, pet owners should:

  • be UK based 
  • register their interest and consent to participate in the study within 14 days of their dog receiving a diagnosis of one of the above conditions
  • be willing to fill out six, five-minute surveys on the quality of life of their dog over 12 months following diagnosis.

For more information and to register your interest, visit rvc.onlinesurveys.ac.uk/immunoregistry

 

Image (C) RVC.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.